On February 8, 2025, the Bureau of Food - Food and Drug Administration (FDA) Thailand reported an incident involving contamination in a product known as Cough Syrup Options. The analysis revealed that tramadol, a medication typically used for pain relief, was detected in the cough syrup. This contamination falls under the category of fraud and is classified specifically as a control hazard due to the presence of contaminants. The FDA Thailand's findings highlight the importance of monitoring and ensuring the safety of pharmaceutical products available to consumers. The detection of tramadol in a cough syrup product raises significant concerns regarding product integrity and consumer safety. Further investigations are likely to follow to ascertain the extent of the issue and to implement necessary measures to prevent similar incidents in the future. The FDA continues to emphasize the need for stringent quality controls within the pharmaceutical industry to protect public health.